Back
Corporate News
Bafna Pharmaceuticals submitted a regulatory filing to BSE and NSE for the September quarter
12-Oct-2026, 07:33
BAFNA PHARMACEUTICALS LIMITED submitted a certificate to the BSE Limited and National Stock Exchange of India Limited on October 12, 2026, concerning Regulation 74(5) of the SEBI (Depositories And Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by its Registrar and Share Transfer Agent, CAMEO CORPORATE SERVICES LIMITED.
